113
Views
21
CrossRef citations to date
0
Altmetric
Original Research

A pilot clinical trial to determine the safety and efficacy of aerosolized hyaluronan as a treatment for COPD

, &
Pages 2747-2752 | Published online: 18 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anita Pye & Alice M Turner. (2019) Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency. Expert Opinion on Investigational Drugs 28:10, pages 891-902.
Read now
Rob Janssen, Ianthe Piscaer, Frits M. E. Franssen & Emiel F. M. Wouters. (2019) Emphysema: looking beyond alpha-1 antitrypsin deficiency. Expert Review of Respiratory Medicine 13:4, pages 381-397.
Read now

Articles from other publishers (19)

Sara Stoilova, Walter Fiore, Valentina Trotta & Michela Mori. (2023) Performance and biocompatibility of a novel inhalable dry powder formulation based on hyaluronic acid intended to protect the respiratory tract mucosa. International Journal of Pharmaceutics 638, pages 122889.
Crossref
Alice Donato, Federico Fontana, Rina Venerando, Antonino Di Stefano & Paola Brun. (2023) The Anti-Inflammatory Effect of Lactose-Modified Hyaluronic Acid Molecules on Primary Bronchial Fibroblasts of Smokers. Polymers 15:7, pages 1616.
Crossref
Anzhu Wang, Zhendong Li, Zhuo Sun, Yicheng Liu, Dawu Zhang & Xiaochang Ma. (2023) Potential Mechanisms Between HF and COPD: New Insights From Bioinformatics. Current Problems in Cardiology 48:3, pages 101539.
Crossref
Henry W. Barnes, Sally Demirdjian, Naomi L. Haddock, Gernot Kaber, Hunter A. Martinez, Nadine Nagy, Harry Karmouty-Quintana & Paul L. Bollyky. (2023) Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection. Matrix Biology 116, pages 49-66.
Crossref
Kathryn M. Crotty & Samantha M. Yeligar. (2022) Hyaladherins May be Implicated in Alcohol-Induced Susceptibility to Bacterial Pneumonia. Frontiers in Immunology 13.
Crossref
Stavros Garantziotis. (2022) Modulation of hyaluronan signaling as a therapeutic target in human disease. Pharmacology & Therapeutics 232, pages 107993.
Crossref
Jerome O. Cantor, Shuren Ma, Xingjian Liu, Michael A. Campos, Charlton Strange, James M. Stocks, Megan S. Devine, Sherif G. El Bayadi, Randolph J. Lipchik, Robert A. Sandhaus & Gerard M. Turino. (2021) A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy. Respiratory Medicine 182, pages 106402.
Crossref
Khushboo Goel, Charlie Strange, Robert A Sandhaus, Irina Petrache & Karina A Serban. (2021) Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung Disease. US Respiratory & Pulmonary Diseases 6:1, pages 26.
Crossref
Meropi Karakioulaki, Eleni Papakonstantinou & Daiana Stolz. (2020) Extracellular matrix remodelling in COPD. European Respiratory Review 29:158, pages 190124.
Crossref
Sara J. Bonvini. (2020) Cause or Effect? Stretching to Understand the Inflammatory Role of Elastin Fiber Breakdown in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology 63:5, pages 558-559.
Crossref
Shadi Mehraban, George Gu, Shuren Ma, Xingjian Liu, Gerard Turino & Jerome Cantor. (2020) The Proinflammatory Activity of Structurally Altered Elastic Fibers. American Journal of Respiratory Cell and Molecular Biology 63:5, pages 699-706.
Crossref
Luis Máiz Carro & Miguel A. Martínez-García. (2020) Use of Hyaluronic Acid (HA) in Chronic Airway Diseases. Cells 9:10, pages 2210.
Crossref
Maria Di Cicco, Diego Peroni, Margherita Sepich, Maria Giulia Tozzi, Pasquale Comberiati & Renato Cutrera. (2020) Hyaluronic acid for the treatment of airway diseases in children: Little evidence for few indications. Pediatric Pulmonology 55:8, pages 2156-2169.
Crossref
Jiapeng Xue, Jinnan Chen, Quan Shen, Deva Chan, Jun Li, Adam P. Tanguay, Tannin A. Schmidt, Faizan Niazi & Anna Plaas. (2020) Addition of High Molecular Weight Hyaluronic Acid to Fibroblast-Like Stromal Cells Modulates Endogenous Hyaluronic Acid Metabolism and Enhances Proteolytic Processing and Secretion of Versican. Cells 9:7, pages 1681.
Crossref
Jerome O. Cantor & Gerard M. Turino. (2019) COPD Pathogenesis. Chest 155:2, pages 266-271.
Crossref
Jerome Cantor. (2018) Giants in Chest Medicine: Gerard M. Turino, MD. Chest 154:6, pages 1274-1275.
Crossref
Beatriz Herrero-CortinaVictoria AlcarazJordi VilaróAntoni TorresEva Polverino. (2018) Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:5, pages 281-289.
Crossref
Gerard M. Turino, Shuren Ma, Yong Y. Lin & Jerome O. Cantor. (2018) The Therapeutic Potential of Hyaluronan in COPD. Chest 153:4, pages 792-798.
Crossref
Gerard M. Turino. (2018) Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy. Annals of the American Thoracic Society 15:Supplement_1, pages S15-S17.
Crossref